Christopher Gerry
President & PEO · Faeth Therapeutics, Inc.
Individual
- 2026
- Jun 13, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Gerry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian C. Stephenson - $1.13M in FTH purchases and sales in the last 12 months
- MILLENNIUM MANAGEMENT LLC - $679K in FTH purchases and sales in the last 12 months
- Cambrian BioPharma Inc - $501K in FTH purchases and sales in the last 12 months
- James Peyer - $501K in FTH purchases and sales in the last 12 months
- Anand Kiran Parikh - $55K in FTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Gerry?
Christopher Gerry is a corporate insider, tracked as President & PEO of Faeth Therapeutics, Inc. (FTH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Christopher Gerry last file a Form 4?
The only primary Form 4 on record is dated 13 June 2026.